These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27009132)

  • 1. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
    Khatak S; Dureja H
    Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles: a review on recent perspectives and patents.
    Paliwal R; Paliwal SR; Kenwat R; Kurmi BD; Sahu MK
    Expert Opin Ther Pat; 2020 Mar; 30(3):179-194. PubMed ID: 32003260
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
    Fang CL; Al-Suwayeh SA; Fang JY
    Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
    Naseri N; Valizadeh H; Zakeri-Milani P
    Adv Pharm Bull; 2015 Sep; 5(3):305-13. PubMed ID: 26504751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLN, NLC, LDC: state of the art in drug and active delivery.
    Attama AA
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):178-87. PubMed ID: 21834777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid Lipid Nanoparticles: Peculiar Strategy to Deliver Bio-Proactive Molecules.
    Minocha N; Sharma N; Verma R; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2023; 17(3):228-242. PubMed ID: 35301957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
    Madkhali OA
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
    Thukral DK; Dumoga S; Mishra AK
    Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
    Uner M
    Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
    Pan Y; Tikekar RV; Nitin N
    Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update of Patents, Preclinical and Clinical Outcomes of Lipid Nanoparticulate Systems.
    Pathak K; Shankar R; Joshi M
    Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29173150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.